Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
< Back to Article Figure 1. Paths and performance of mice in the probe trial. A : Escape latency in the three groups from day 1 to 5. (Day 2: * P <0.05; Days 3, 4, 5: ** P <0.01). B : The photographs, from the…
Read guide →Our histone peptides are derived from human Histone H1, Histone H2A, Histone H2B , Histone H3 and Histone H4 . Supplied in 0.5mg amounts, these peptides may contain various post-translational modifications or …
Read guide →Immune Peptides Thymosin Alpha 1 Thymosin a-1 is a major component of Thymosin Fraction 5 and responsible for restoring immune function, particularly cell mediated immune function. Recent studies showed that t…
Read guide →Summary: Researchers reversed Alzheimer’s symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that PHDP5 can cross the blood-brain barrier and restore memory by impr…
Read guide →Introduction Alzheimer's disease (AD), characterized by the extracellular senile plaques constituted of amyloid-β (Aβ) peptides and the intraneuronal neurofibrillary tangles composed of hyperphosphorylated tau…
Read guide →GJPPS.MS.ID.555569 Mini Review Nasal Delivery of Proteins and Peptides Department of Pharmaceutical Sciences, St. John's University, USA Submission: February 13, 2017; Published: April 10, 2017 *Corresponding …
Read guide →The peptide field is evolving, with high-throughput platforms and biologically relevant systems driving the next generation of leads with powerful discovery platforms including AI/ML, high-throughput screening…
Read guide →Abstract β-amyloid hypothesis is the predominant hypothesis in the study of pathogenesis of Alzheimer's disease. This hypothesis claims that aggregation and neurotoxic effects of amyloid β (Aβ) is the common p…
Read guide →MIT neuroscientists have found a way to reverse neurodegeneration and other symptoms of Alzheimer’s disease by interfering with an enzyme that is typically overactive in the brains of Alzheimer’s patients. Whe…
Read guide →β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling. Author : W Liu F Sun M Wan F Jiang X Bo L Lin H Tang S Xu Abstract : Bac…
Read guide →Abstract Alzheimer's disease (AD) is a complex neurodegenerative disease with few effective treatments. The non-targeted distribution of drugs decreases drug efficiency and cause side effects. The cascade targ…
Read guide →Loading metrics Open Access Peer-reviewed Research Article Xiang-yu Bo , Yuan-zhen Tan, Feng-xian Sun, Ming Song, Juan Zhao, Zhi-hong Ma, Mei Li, Kai-jun Zheng, Shu-mei Xu Feasibility of β-Sheet Breaker Peptid…
Read guide →Resources Peptide Resources Peptide Therapy Certification Partners Member Portal News & Events About Contact × Resources Peptide Resources Peptide Therapy Certification Partners Member Portal News & Events Abo…
Read guide →